Similar Items: Clinical impact of bacterial heteroresistance
- ADVANCE-ID bacterial and fungal infections review: antimicrobial resistance research updatesSummary of clinical trials and implementation studies, March–April 2026
- Current practices and challenges in the management of acute bacterial skin and skin structure infections (ABSSSI): results from an Italian multicentre survey with expert discussion
- Patients referred to but not taken on to an outpatient parenteral antimicrobial therapy (OPAT) service: the impact of infection specialist advice on the assessment and clinical outcomes
- Defining a target product profile for antimicrobials to treat severe paediatric bacterial enteric infections in low- and medium-income countries, caused by E. coli, Shigella, Salmonella and Campylobacter species
- Impact of an integrated electronic Clinical Decision Support System with proactive Antimicrobial Stewardship Feedback on prescribing appropriateness: a 2-year single-centre time-series analysis
- Comparison of the clinical performance of airway management with the i-gel